Skip to main content

Table 2 Association of MLKL mRNA with clinical pathological parameters of SLE

From: Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity

Clinical parameters

Data (mean ± SD)

Relative MLKL mRNA expression

r

p

Age (years)

33.68 ± 13.55

− 0.0132

0.346

ESR (mm/h)

36.10 ± 28.22

0.4091

0.0043

CRP (mg/L)

8.64 ± 24.03

0.3577

0.0237

IgG total (g/L)

13.80 ± 4.55

0.3546

0.0289

IgM total (g/L)

1.07 ± 0.49

− 0.1166

0.4919

IgA total (g/L)

2.59 ± 1.27

0.148

0.3821

C1q (ng/L)

177.80 ± 46.61

− 0.0421

0.8047

C3 (g/L)

4.92 ± 24.99

− 0.0439

0.7936

C4 (g/L)

0.18 ± 0.10

− 0.1836

0.2766

D-dimer (g/L)

397.4 ± 771.30

− 0.0569

0.7488

Leukocyte count (× 109/L)

6.62 ± 2.68

− 0.0317

0.8382

Lymphocyte count (× 109/L)

1.81 ± 0.72

0.1263

0.3819

Positive ANA numbers

2.78 ± 2.56

0.3945

0.0432

Anti-dsDNA antibody (IU/mL)

59.73 ± 113.3

0.1265

0.5214

Anti-Nuc antibody (RU/mL)

84.39 ± 139.60

0.0328

0.8656

Anti-Sm antibody (RU/mL)

41.75 ± 98.59

0.2085

0.3282